Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1980 Oct;77(10):5943–5947. doi: 10.1073/pnas.77.10.5943

Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70.

C L Reading, K W Brunson, M Torrianni, G L Nicolson
PMCID: PMC350188  PMID: 6934525

Abstract

Variant sublines of the murine lymphosarcoma RAW117 have been derived by sequential cycles of intravenous inoculation of cells and harvesting of solid liver tumors in syngeneic BALB/c mice [Brunson K. W. & Nicolson, G. L. (1978) J. Natl. Cancer Inst. 61, 1499-1503] and also by sequential removal of lectin-reactive cells via repeated adsorption on immobilized-lectins [Reading, C. L. Belloni, P. N. & Nicolson, G. L. (1980) J. Natl. Cancer Inst. 64, 1241-1249]. These cell sublines and their clones were analyzed for abilities to form gross liver tumor metastases after injection intravenously or subcutaneously into syngeneic mice, and this response was related to certain cell surface properties including quantities of viral antigens and lectin-binding sites, exposure of specific cell surface proteins, and quantities of cell surface glycoproteins visualized in gels with 125I-labeled lectins or antibodies. Consistent differences were obtained between RAW117 sublines of low and high malignancy with respect to the amounts or exposures of cell surface glycoprotein components of Mr approximately 70,000 or 69,000 and 71,000, depending on the gel system. Competition radioimmunoassays for RNA tumor virus antigens in the RAW117 lines and clones indicated the presence of Moloney murine leukemic virus antigens gp70, p30, and p12. Enhanced malignancy and metastasis to liver was accompanied by decreases in the cellular contents of viral antigens and loss of gp70 cell surface exposure. Analysis of several clones obtained from sublines selected in vivo and in vitro for high or low malignancy confirmed the inverse relationship between metastasis and expression of gp70 in this system.

Full text

PDF
5943

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arcement L. J., Karshin W. L., Naso R. B., Arlinghaus R. B. "gag" polyprotein precursors of Rauscher murine leukemia virus. Virology. 1977 Sep;81(2):284–297. doi: 10.1016/0042-6822(77)90145-3. [DOI] [PubMed] [Google Scholar]
  2. Boiocchi M., Nowinski R. C. Antibodies to the envelope protein (gp70) of endogenous xenotropic and ecotropic leukemia viruses: induction by immunization with leukemia cells. Virology. 1979 Jul 15;96(1):281–285. doi: 10.1016/0042-6822(79)90194-6. [DOI] [PubMed] [Google Scholar]
  3. Briles E. B., Kornfeld S. Isolation and metastatic properties of detachment variants of B16 melanoma cells. J Natl Cancer Inst. 1978 Jun;60(6):1217–1222. doi: 10.1093/jnci/60.6.1217. [DOI] [PubMed] [Google Scholar]
  4. Brunson K. W., Beattie G., Nicolsin G. L. Selection and altered properties of brain-colonising metastatic melanoma. Nature. 1978 Apr 6;272(5653):543–545. doi: 10.1038/272543a0. [DOI] [PubMed] [Google Scholar]
  5. Brunson K. W., Nicolson G. L. Selection and biologic properties of malignant variants of a murine lymphosarcoma. J Natl Cancer Inst. 1978 Dec;61(6):1499–1503. [PubMed] [Google Scholar]
  6. Burridge K. Changes in cellular glycoproteins after transformation: identification of specific glycoproteins and antigens in sodium dodecyl sulfate gels. Proc Natl Acad Sci U S A. 1976 Dec;73(12):4457–4461. doi: 10.1073/pnas.73.12.4457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Callahan R. M., Marx P. A., Wheelock E. F. Group-specific cytolytic antibody directed against the major glycoprotein (gp70) of murine leukemia viruses in serum of mice with dormant FLV infections. Virology. 1979 Aug;97(1):55–67. doi: 10.1016/0042-6822(79)90372-6. [DOI] [PubMed] [Google Scholar]
  8. Caulfield M. J., Cerny J. Cell interactions in leukemia-associated immunosuppression: suppression of thymus-independent antibody responses by leukemia spleen cells (Moloney) in vitro is mediated by normal T cells. J Immunol. 1980 Jan;124(1):255–260. [PubMed] [Google Scholar]
  9. Cleveland P. H., Belnap L. P., Knotts F. B., Nayak S. K., Baird S. M., Pilch Y. H. Tumor-associated antigens of chemically-induced murine tumors; the emergence of MuLV and fetal antigens after serial passage in culture. Int J Cancer. 1979 Mar 15;23(3):380–391. doi: 10.1002/ijc.2910230317. [DOI] [PubMed] [Google Scholar]
  10. Cuatrecasas P. Interaction of wheat germ agglutinin and concanavalin A with isolated fat cells. Biochemistry. 1973 Mar 27;12(7):1312–1323. doi: 10.1021/bi00731a011. [DOI] [PubMed] [Google Scholar]
  11. Debre P., Gisselbrecht S., Pozo F., Levy J. P. Genetic control of sensitivity to Moloney leukemia virus in mice. II. Mapping of three resistant genes within the H-2 complex. J Immunol. 1979 Oct;123(4):1806–1812. [PubMed] [Google Scholar]
  12. Dexter D. L., Kowalski H. M., Blazar B. A., Fligiel Z., Vogel R., Heppner G. H. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res. 1978 Oct;38(10):3174–3181. [PubMed] [Google Scholar]
  13. Fefer A., McCoy J. L., Glynn J. P. Antigenicity of a virus-induced murine sarcoma (Moloney). Cancer Res. 1967 May;27(5):962–967. [PubMed] [Google Scholar]
  14. Fenyö E. M., Klein G. Independence of Moloney virus-induced cell-surface antigen and membrane-associated virion antigens in immunoselected lymphoma sublines. Nature. 1976 Mar 25;260(5549):355–357. doi: 10.1038/260355a0. [DOI] [PubMed] [Google Scholar]
  15. Fidler I. J., Gersten D. M., Budmen M. B. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res. 1976 Sep;36(9 PT1):3160–3165. [PubMed] [Google Scholar]
  16. Fidler I. J., Gersten D. M., Hart I. R. The biology of cancer invasion and metastasis. Adv Cancer Res. 1978;28:149–250. doi: 10.1016/s0065-230x(08)60648-x. [DOI] [PubMed] [Google Scholar]
  17. Fidler I. J., Kripke M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science. 1977 Aug 26;197(4306):893–895. doi: 10.1126/science.887927. [DOI] [PubMed] [Google Scholar]
  18. Fidler I. J. Selection of successive tumour lines for metastasis. Nat New Biol. 1973 Apr 4;242(118):148–149. doi: 10.1038/newbio242148a0. [DOI] [PubMed] [Google Scholar]
  19. Gomard E., Leclerc J. C., Levy J. P. Spontaneous antilymphoma reaction of preleukaemic AKR mice is a non-T-cell killing. Nature. 1974 Aug 23;250(5468):671–673. doi: 10.1038/250671a0. [DOI] [PubMed] [Google Scholar]
  20. Hayman M. Synthesis and processing of avian sarcoma virus glycoproteins. Virology. 1978 Apr;85(2):475–486. doi: 10.1016/0042-6822(78)90454-3. [DOI] [PubMed] [Google Scholar]
  21. Hino S., Stephenson J. R., Aaronson S. A. Radiommunoassays for the 70,000-molecular-weight glycoproteins of endogenous mouse type C viruses: viral antigen expression in normal mouse tissues and sera. J Virol. 1976 Jun;18(3):933–941. doi: 10.1128/jvi.18.3.933-941.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hynes R. O. Cell surface proteins and malignant transformation. Biochim Biophys Acta. 1976 Apr 30;458(1):73–107. doi: 10.1016/0304-419x(76)90015-9. [DOI] [PubMed] [Google Scholar]
  23. Ihle J. N., Lazar B. Natural immunity in mice to the envelope glycoprotein of endogenous ecotropic type C viruses: neutralization of virus infectivity. J Virol. 1977 Mar;21(3):974–980. doi: 10.1128/jvi.21.3.974-980.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Karande A., Yefenof E., Fenyö E. M., Klein G. Moloney lymphoma cells express a polyprotein containing the GAG gene-coded p15 and the Moloney leukemia virus-induced cell surface antigen (MCSA). Int J Cancer. 1979 Apr 15;23(4):508–513. doi: 10.1002/ijc.2910230411. [DOI] [PubMed] [Google Scholar]
  25. Kende M., Hill R., Dinowitz M., Stephenson J. R., Kelloff G. J. Naturally occurring lymphocyte-mediated immunity to endogenous type-C virus in the mouse. Blocking of the lymphocyte reactivity with antisera to the virus. J Exp Med. 1979 Feb 1;149(2):358–371. doi: 10.1084/jem.149.2.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kennel S. J. Purification of a glycoprotein from mouse ascites fluid by immunoaffinity chromatography which is related to the major glycoprotein of murine leukemia viruses. Immunologic and structural comparison with purified viral glycoproteins. J Biol Chem. 1976 Oct 25;251(20):6197–6204. [PubMed] [Google Scholar]
  27. Kerbel R. S., Twiddy R. R., Robertson D. M. Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H-2 incompatible parental strain. Int J Cancer. 1978 Nov 15;22(5):583–594. doi: 10.1002/ijc.2910220513. [DOI] [PubMed] [Google Scholar]
  28. Kim U. Metastasizing mammary carcinomas in rats: induction and study of their immunogenicity. Science. 1970 Jan 2;167(3914):72–74. doi: 10.1126/science.167.3914.72. [DOI] [PubMed] [Google Scholar]
  29. Kripke M. L., Gruys E., Fidler I. J. Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res. 1978 Sep;38(9):2962–2967. [PubMed] [Google Scholar]
  30. Lee J. C., Ihle J. N. Mechanisms of C-type viral leukemogenesis. I. Correlation of in vitro lymphocyte blastogenesis to viremia and leukemia. J Immunol. 1979 Nov;123(5):2351–2358. [PubMed] [Google Scholar]
  31. Lerner R. A., Wilson C. B., Villano B. C., McConahey P. J., Dixon F. J. Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, and physiologic studies of the major viral glycorprotein, gp70. J Exp Med. 1976 Jan 1;143(1):151–166. doi: 10.1084/jem.143.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Marquardt H., Gilden R. V., Oroszlan S. Envelope glycoproteins of Rauscher murine leukemia virus: isolation and chemical characterization. Biochemistry. 1977 Feb 22;16(4):710–717. doi: 10.1021/bi00623a024. [DOI] [PubMed] [Google Scholar]
  33. McClintock P. R., Ihle J. N., Joseph D. R. Expression of AKR murine leukemia virus gp71-like and BALB(X) gp-71-like antigens in normal mouse tissues in the absence of overt virus expression. J Exp Med. 1977 Aug 1;146(2):422–434. doi: 10.1084/jem.146.2.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. McGinnis J., Hizi A., Smith R. E., Leis J. P. In vitro translation of a 180,000-dalton Rous sarcoma virus precursor polypeptide containing both the DNA polymerase and the group-specific antigens. Virology. 1978 Feb;84(2):518–522. doi: 10.1016/0042-6822(78)90267-2. [DOI] [PubMed] [Google Scholar]
  35. Morse H. C., 3rd, Chused T. M., Boehm-Truitt M., Mathieson B. J., Sharrow S. O., Hartley J. W. XenCSA: cell surface antigens related to the major glycoproteins (gp70) of xenotropic murine leukemia viruses. J Immunol. 1979 Feb;122(2):443–454. [PubMed] [Google Scholar]
  36. Murphy E. C., Jr, Arlinghaus R. B. Cell-free synthesis of Rauscher murine leukemia virus "gag" and "gag-pol" precursor polyproteins from virion 35 S RNA in a mRNA-dependent translation system derived from mouse tissue culture cells. Virology. 1978 May 15;86(2):329–343. doi: 10.1016/0042-6822(78)90074-0. [DOI] [PubMed] [Google Scholar]
  37. Naso R. B., Arcement L. J., Arlinghaus R. B. Biosynthesis of Rauscher leukemia viral proteins. Cell. 1975 Jan;4(1):31–36. doi: 10.1016/0092-8674(75)90130-0. [DOI] [PubMed] [Google Scholar]
  38. Ng A. K., Ames R. S., Jr, McIntire R. K., Herberman R. B. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens. Cancer Res. 1979 Dec;39(12):4887–4893. [PubMed] [Google Scholar]
  39. Nicolson G. L., Birdwell C. R., Brunson K. W., Robbins J. C., Beattie G., Fidler I. J. Cell interactions in the metastatic process: some cell surface properties associated with successful blood-borne tumor spread. Soc Gen Physiol Ser. 1977;32:225–241. [PubMed] [Google Scholar]
  40. Nicolson G. L., Brunson K. W., Fidler I. J. Specificity of arrest, survival, and growth of selected metastatic variant cell lines. Cancer Res. 1978 Nov;38(11 Pt 2):4105–4111. [PubMed] [Google Scholar]
  41. Nicolson G. L. Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy. Biochim Biophys Acta. 1976 Apr 30;458(1):1–72. doi: 10.1016/0304-419x(76)90014-7. [DOI] [PubMed] [Google Scholar]
  42. Obata Y., Tanaka T., Stockert E., Good R. A. Autoimmune and lymphoproliferative disease in (B6-GIX+ X 129)F1 mice: relation to naturally occurring antibodies against murine leukemia virus-related cell surface antigens. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5289–5293. doi: 10.1073/pnas.76.10.5289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Oppermann H., Bishop J. M., Varmus H. E., Levintow L. A joint produce of the genes gag and pol of avian sarcoma virus: a possible precursor of reverse transcriptase. Cell. 1977 Dec;12(4):993–1005. doi: 10.1016/0092-8674(77)90164-7. [DOI] [PubMed] [Google Scholar]
  44. Plata F., MacDonald H. R., Shain B. Suppressor T cells regulate the cytolytic T lymphocyte response to syngeneic tumors induced by murine sarcoma virus (MSV) in the mouse. J Immunol. 1979 Aug;123(2):852–860. [PubMed] [Google Scholar]
  45. Poste G., Nicolson G. L. Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci U S A. 1980 Jan;77(1):399–403. doi: 10.1073/pnas.77.1.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Raz A., McLellan W. L., Hart I. R., Bucana C. D., Hoyer L. C., Sela B. A., Dragsten P., Fidler I. J. Cell surface properties of B16 melanoma variants with differing metastatic potential. Cancer Res. 1980 May;40(5):1645–1651. [PubMed] [Google Scholar]
  47. Reading C. L., Belloni P. N., Nicolson G. L. Selection and in vivo properties of lectin-attachment variants of malignant murine lymphosarcoma cell lines. J Natl Cancer Inst. 1980 May;64(5):1241–1249. [PubMed] [Google Scholar]
  48. Reynolds F. H., Jr, Hanson C. A., Stephenson J. R. Biochemical properties of avian type-C virus gag gene-coded proteins: comparison with structural proteins coded for at analogous positions within the mammalian type-C viral genome. Virology. 1978 May 1;86(1):177–185. doi: 10.1016/0042-6822(78)90018-1. [DOI] [PubMed] [Google Scholar]
  49. Rieber M., Rieber M., Alonso M. Antiserum to murine leukemia virus recognizes novel cell surface molecules associated with growth control and transformation. Int J Cancer. 1979 Apr 15;23(4):547–554. doi: 10.1002/ijc.2910230417. [DOI] [PubMed] [Google Scholar]
  50. Risser R. Abelson antigen is expressed on hematopoietic spleen colony-forming cells from mice carrying the Av-2S virus sensitivity gene. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5350–5354. doi: 10.1073/pnas.76.10.5350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Risser R., Stockert E., Old L. J. Abelson antigen: a viral tumor antigen that is also a differentiation antigen of BALB/c mice. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3918–3922. doi: 10.1073/pnas.75.8.3918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Sacks T. L., Devare S. G., Blennerhassett G. T., Stephenson J. R. Nonconditional replication mutants of type C and type D retroviruses defective in gag gene-coded polyprotein post-translational processing. Virology. 1978 Dec;91(2):352–363. doi: 10.1016/0042-6822(78)90383-5. [DOI] [PubMed] [Google Scholar]
  53. Schirrmacher V., Shantz G., Clauer K., Komitowski D., Zimmermann H. P., Lohmann-Matthes M. L. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo. Int J Cancer. 1979 Feb;23(2):233–244. doi: 10.1002/ijc.2910230215. [DOI] [PubMed] [Google Scholar]
  54. Schwarz H., Fischinger P. J., Ihle J. N., Thiel H. J., Weiland F., Bolognesi D. P., Schäfer W. Properties of mouse leukemia viruses. XVI. Suppression of spontaneous fetal leukemias in AKR mice by treatment with broadly reacting antibody against the viral glycoprotein gp 71. Virology. 1979 Feb;93(1):159–174. doi: 10.1016/0042-6822(79)90284-8. [DOI] [PubMed] [Google Scholar]
  55. Shapiro S. Z., Strand M., August J. T. High molecular weight precursor polypeptides to structural proteins of Rauscher murine leukemia virus. J Mol Biol. 1976 Nov 15;107(4):459–477. doi: 10.1016/s0022-2836(76)80078-2. [DOI] [PubMed] [Google Scholar]
  56. Stephenson J. R., Aaronson S. A. Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells. J Exp Med. 1972 Mar 1;135(3):503–515. doi: 10.1084/jem.135.3.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Stockert E., Old L. J., Boyse E. A. The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome. J Exp Med. 1971 Jun 1;133(6):1334–1355. doi: 10.1084/jem.133.6.1334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Strand M., August J. T. Polypeptide maps of cells infected with murine type C leukemia or sarcoma oncovirus. Cell. 1978 Feb;13(2):399–408. doi: 10.1016/0092-8674(78)90208-8. [DOI] [PubMed] [Google Scholar]
  59. Strand M., Lilly F., August J. T. Genetic control of the expression of murine leukemia virus proteins in tissues of normal, young adult mice. Cold Spring Harb Symp Quant Biol. 1975;39(Pt 2):1117–1122. doi: 10.1101/sqb.1974.039.01.127. [DOI] [PubMed] [Google Scholar]
  60. Sugarbaker E. V. Cancer metastasis: a product of tumor-host interactions. Curr Probl Cancer. 1979 Jan;3(7):1–59. doi: 10.1016/s0147-0272(79)80008-2. [DOI] [PubMed] [Google Scholar]
  61. Suzuki N., Withers H. R., Koehler M. W. Heterogeneity and variability of artificial lung colony-forming ability among clones from mouse fibrosarcoma. Cancer Res. 1978 Oct;38(10):3349–3351. [PubMed] [Google Scholar]
  62. Tao T. W., Burger M. M. Non-metastasising variants selected from metastasising melanoma cells. Nature. 1977 Dec 1;270(5636):437–438. doi: 10.1038/270437a0. [DOI] [PubMed] [Google Scholar]
  63. Troy F. A., Fenyö E. M., Klein G. Moloney leukemia virus-induced cell surface antigen: detection and characterization in sodium dodecyl sulfate gels. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5270–5274. doi: 10.1073/pnas.74.12.5270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Tung J. S., Shen F. W., Fleissner E., Boyse E. A. X-gp70: a third molecular species of the envelope protein gp70 of murine leukemia virus, expressed on mouse lymphoid cells. J Exp Med. 1976 Apr 1;143(4):969–974. doi: 10.1084/jem.143.4.969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Van Eldik L. J., Paulson J. C., Green R. W., Smith R. E. The influence of carbohydrate on the antigenicity of the envelope glycoprotein of avian myeloblastosis virus and B77 avian sarcoma virus. Virology. 1978 May 1;86(1):193–204. doi: 10.1016/0042-6822(78)90020-x. [DOI] [PubMed] [Google Scholar]
  66. Witte O. N., Rosenberg N., Paskind M., Shields A., Baltimore D. Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells. Proc Natl Acad Sci U S A. 1978 May;75(5):2488–2492. doi: 10.1073/pnas.75.5.2488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Yoshiki T., Mellors R. C., Hardy W. D., Jr Common cell-surface antigen associated with murine and feline C-type RNA leukemia viruses. Proc Natl Acad Sci U S A. 1973 Jun;70(6):1878–1882. doi: 10.1073/pnas.70.6.1878. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES